HMN:NYSEHorace Mann Educators Corporation Analysis
Data as of 2026-04-08 - not real-time
$43.96
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
Horace Mann is trading just above its 20‑day and 50‑day moving averages at $43.96, yet remains below the 200‑day average, signaling a short‑term pullback within a longer‑term downtrend. The MACD has turned bullish with a positive histogram, while the RSI sits at 60, indicating modest upward momentum but no overbought alarm. Support around $41.29 and resistance near $44.31 frame the next price action, and a decreasing volume trend suggests waning short‑term enthusiasm. With a beta of only 0.27 and 30‑day volatility under 20%, the stock exhibits low market‑risk sensitivity. Valuation metrics are compelling: a trailing P/E of 11.3 is well under the industry average of 16.8, and the discounted cash‑flow model points to a fair value of roughly $51, implying about 17% upside. Dividend sustainability looks strong, highlighted by a 3% quarterly increase to $0.36 per share, a 3.28% yield and a modest 36% payout ratio supported by solid free cash flow. Recent insider buying and an upcoming earnings release add a layer of confidence, though the company’s high debt‑to‑equity ratio tempers enthusiasm.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near resistance with bullish MACD but bearish trend direction
- Decreasing volume indicating limited near‑term buying pressure
- Attractive dividend yield and recent dividend increase
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- DCF implied upside of ~17% and P/E well below industry average
- Sustainable dividend with low payout ratio and strong cash flow
- Insider buying and upcoming earnings release suggesting confidence
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Stable insurance business with low beta and modest volatility
- Consistent dividend growth and solid ROE around 12%
- Value orientation with a significant valuation gap to fair value
Key Metrics & Analysis
Financial Health
Revenue Growth6.30%
Profit Margin9.53%
P/E Ratio11.3
ROE11.70%
ROA1.00%
Debt/Equity110.13
P/B Ratio1.2
Op. Cash Flow$553.2M
Free Cash Flow$197.1M
Industry P/E16.8
Technical Analysis
TrendBearish
RSI60.2
Support$41.29
Resistance$44.31
MA 20$42.56
MA 50$43.04
MA 200$44.10
MACDBullish
VolumeDecreasing
Fear & Greed Index84.89
Valuation
Fair Value$51.28
Target Price$51.50
Upside/Downside17.15%
GradeUndervalued
TypeBlend
Dividend Yield3.28%
Risk Assessment
Beta0.27
Volatility18.77%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.